Work

Profiling of exceptional responders (ER) and non-responders (NR) to androgen receptor pathway inhibitors (ARPI) in men with metastatic hormone sensitive and castration resistant prostate cancer.

Year: 2025

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17107

Authors: Jane McKenzie, Lauren Howard, Joseph J. Park, Bilal Ashraf, Tara Seibert, Kallie White, Sundhar Ramalingam, Jeffrey Shevach, Michael Roger Harrison, Christopher J. Hoimes, Matthew Labriola, Hannah Dzimitrowicz McManus, Shahla Bari, Daniel J. George, Andrew J. Armstrong

Institutions: Duke University, Duke Medical Center, Duke Cancer Institute, Durham VA Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809213

Cites:

Cited by:

Related to: 10